Peak Bio, Inc. financial data

Symbol
PKBO on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
4900 Hopyard Road, Suite 100, Pleasanton, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Ignyte Acquisition Corp. (to 11/2/2022)
Latest financial report
10-K - Q4 2023 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 10.1 % -60.2%
Debt-to-equity -112 % -4.39%
Return On Equity 73.9 % -71.5%
Return On Assets -598 % -1968%
Operating Margin -3.55K % -82.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.1M shares +10.8%
Common Stock, Shares, Outstanding 23.1M shares +16.9%
Entity Public Float 17M USD -70%
Common Stock, Value, Issued 2.31K USD +16.9%
Weighted Average Number of Shares Outstanding, Basic 21.2M shares +19.6%
Weighted Average Number of Shares Outstanding, Diluted 21.2M shares +19.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 368K USD -39.5%
Research and Development Expense 1.63M USD -58.5%
General and Administrative Expense 8.29M USD -2.8%
Operating Income (Loss) -13.1M USD -10.3%
Nonoperating Income (Expense) 240K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12.8M USD +2.56%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -12.8M USD +2.01%
Earnings Per Share, Basic -0.61 USD/shares +17.6%
Earnings Per Share, Diluted -0.61 USD/shares +17.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 382K USD -41.7%
Assets, Current 2.37M USD -26.5%
Property, Plant and Equipment, Net 153K USD -59.4%
Operating Lease, Right-of-Use Asset 0 USD -100%
Goodwill 0 USD
Other Assets, Noncurrent 9.2K USD +513%
Assets 2.6M USD -65.5%
Accounts Payable, Current 5.86M USD +62%
Accrued Liabilities, Current 3.58M USD +75.5%
Liabilities, Current 20.5M USD +90%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 231K USD -70.8%
Liabilities 20.8M USD +32.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 93.6K USD +217%
Retained Earnings (Accumulated Deficit) -38.2M USD -50.6%
Stockholders' Equity Attributable to Parent -18.2M USD -124%
Liabilities and Equity 2.6M USD -65.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.44M USD -23.5%
Net Cash Provided by (Used in) Financing Activities 1.14M USD -8.49%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 23.1M shares +6.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 442K USD -50.6%
Deferred Tax Assets, Valuation Allowance 16M USD -44.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 16.1M USD -46.4%
Operating Lease, Liability 4.35M USD
Depreciation 41.4K USD +0.73%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.8M USD +2.94%
Lessee, Operating Lease, Liability, to be Paid 5.07M USD
Property, Plant and Equipment, Gross 753K USD -11.2%
Operating Lease, Liability, Current 4.44M USD +516%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.22M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.19M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 723K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.26M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 422K USD
Operating Lease, Payments 177K USD -77.5%
Additional Paid in Capital 19.9M USD +15.7%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 16M USD -44.5%
Share-based Payment Arrangement, Expense 275K USD -50.8%
Interest Expense 2.73M USD +5589%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%